Panacea Biotec Ltd
NSE:PANACEABIO

Watchlist Manager
Panacea Biotec Ltd Logo
Panacea Biotec Ltd
NSE:PANACEABIO
Watchlist
Price: 433.25 INR 0.97%
Market Cap: 26.5B INR
Have any thoughts about
Panacea Biotec Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Panacea Biotec Ltd

Current Assets 5B
Cash & Short-Term Investments 2B
Receivables 670.8m
Other Current Assets 2.3B
Non-Current Assets 7.4B
Long-Term Investments 192.3m
PP&E 6.3B
Intangibles 350.5m
Other Non-Current Assets 549.5m
Current Liabilities 3.3B
Accounts Payable 1.7B
Other Current Liabilities 1.6B
Non-Current Liabilities 823.6m
Long-Term Debt 215.7m
Other Non-Current Liabilities 607.9m

Balance Sheet
Panacea Biotec Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
200
96
91
164
145
402
1 358
504
363
537
Cash
200
96
91
164
145
401
521
478
362
472
Cash Equivalents
0
0
0
0
0
1
837
26
0
65
Short-Term Investments
370
63
53
88
90
495
129
5 397
1 712
1 043
Total Receivables
1 539
1 617
1 924
1 820
1 241
761
867
1 342
1 096
1 114
Accounts Receivables
986
1 234
1 422
1 360
887
685
847
1 317
601
574
Other Receivables
553
383
502
460
354
76
20
25
495
539
Inventory
3 102
3 075
3 156
3 342
814
1 562
1 741
2 190
2 056
1 827
Other Current Assets
46
1 786
1 774
189
2 788
3 612
1 015
973
456
396
Total Current Assets
5 257
6 637
6 997
5 603
5 079
6 833
5 110
10 406
5 683
4 852
PP&E Net
12 597
10 512
10 023
9 504
8 115
6 650
6 279
5 927
6 163
6 348
PP&E Gross
12 597
10 512
10 023
9 504
8 115
6 650
0
5 927
6 163
6 348
Accumulated Depreciation
4 212
4 623
5 191
5 751
5 059
5 352
0
6 115
6 469
6 562
Intangible Assets
333
230
286
376
166
164
152
138
259
360
Goodwill
67
9
9
9
0
0
0
0
0
0
Note Receivable
670
307
265
280
133
175
26
202
555
690
Long-Term Investments
102
127
122
105
64
62
69
849
2
128
Other Long-Term Assets
278
208
299
198
198
19
140
303
49
30
Other Assets
67
9
9
9
0
0
0
0
0
0
Total Assets
19 305
N/A
18 030
-7%
18 001
0%
16 076
-11%
13 755
-14%
13 903
+1%
11 775
-15%
17 825
+51%
12 712
-29%
12 407
-2%
Liabilities
Accounts Payable
2 091
1 882
2 486
2 772
2 697
1 989
2 467
2 598
1 773
1 537
Accrued Liabilities
948
277
159
57
85
548
0
163
110
102
Short-Term Debt
2 958
1 893
1 907
1 649
694
36
844
0
0
0
Current Portion of Long-Term Debt
761
220
888
2 052
5 310
1 255
0
1
1
0
Other Current Liabilities
302
1 400
1 417
381
597
725
1 180
5 266
1 435
1 450
Total Current Liabilities
7 060
5 672
6 856
6 910
9 383
4 552
4 491
8 028
3 318
3 088
Long-Term Debt
7 230
7 857
7 141
5 707
461
6 131
7 351
341
202
210
Deferred Income Tax
5
145
111
93
0
0
0
0
204
225
Minority Interest
34
123
105
29
30
30
30
30
35
38
Other Liabilities
263
198
231
308
437
1 262
2 251
998
587
501
Total Liabilities
14 592
N/A
13 994
-4%
14 445
+3%
12 989
-10%
10 251
-21%
11 915
+16%
14 062
+18%
9 337
-34%
4 276
-54%
3 986
-7%
Equity
Common Stock
224
61
61
61
61
61
61
61
61
61
Retained Earnings
899
3 263
2 710
2 107
2 478
958
2 348
7 467
7 398
7 383
Additional Paid In Capital
920
919
919
919
919
919
0
919
919
919
Unrealized Security Profit/Loss
4 595
0
0
0
0
0
0
0
0
0
Other Equity
128
208
134
1
45
49
0
40
58
57
Total Equity
4 713
N/A
4 036
-14%
3 557
-12%
3 087
-13%
3 504
+14%
1 988
-43%
2 287
N/A
8 488
N/A
8 436
-1%
8 420
0%
Total Liabilities & Equity
19 305
N/A
18 030
-7%
18 001
0%
16 076
-11%
13 755
-14%
13 903
+1%
11 775
-15%
17 825
+51%
12 712
-29%
12 407
-2%
Shares Outstanding
Common Shares Outstanding
61
61
61
61
61
61
61
61
61
61
Preferred Shares Outstanding
16
16
16
16
16
16
16
16
16
16

See Also

Discover More